Team Furocyst had conducted the CME conference of Obs./Gyn. doctors- Mohali Chapter on 6th January, 2016 at Hotel Cama, Mohali. Speaker Dr Vinnet Nagpal, Sr consultant at Civil Hospital, mohali made emphatic remarks on study results of Furocyst & suggested to prescibed as alternate nutritional/dietary supplement option to pcos patients.
Hon’able Sh.Nitin Gadkari, Union Transport and Highways Minister visited our stall at R&D Sumit, Vigyan Bhawan, New Delhi on dated 07-08 December, 2015
Abstract has been accepted as a poster presentation- ‘Clinical evaluation of fenugreek seed extract (Fenfuro) in patients with type-2 diabetes: an add-on study in 154 patients’ at the 43rd annual conference of Research Society for the Study of Diabetes in India – RSSDI 2015 at Lucknow, UP (30th, 31st October & 1st November 2015).
Poster Presented on “Clinical evaluation of Standardized Fenugreek seed extract as Furostanolic Saponins (Furocyst) in Polycystic Ovary Syndome Patients at FIGO 2015 Congress at Vancouver, Canada on 4-9 October 2015.
Poster Presented on “Clinical evaluation of Standardized Fenugreek seed extract as Furostanolic Saponins (Furocyst) in Polycystic Ovary Syndome Patients at FIGO 2015 Congress at Vancouver, Canada on 4-9 October 2015.
We have granted patent to our product Pygeum in U.S. under the title ‘IMPROVED PROCESS FOR PYGEUM EXTRACTION’.
People who need treating with repeated courses of antibiotics may be at increased risk of developing type 2 diabetes, researchers have found. The European Journal of Endocrinology study traced antibiotic prescriptions given out to a million UK patients. The authors say the findings do not necessarily mean that the drugs trigger diabetes – instead, infections…
We are glad to inform that our company has been awarded ‘Asia Pacific Most Promising Enterpreneurship Award.’